Ahmad Doroudian

All filings by Ahmad Doroudian on record concern Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.). In total, 18 filings cover trades dated from 18 March 2010 to 30 October 2018.

The open-market record is one-sided, with 5 purchases worth €89k and not one sale. The totals exclude 2 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2023 alone, the filings show 1 purchase and no sales.

In size, the median ticket on the buying side is €34k. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The latest filing, published on 17 November 2023, reports an open-market purchase of €4,106 in Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.). This summary is built from SEDI disclosures alone and does not predict where the share price will go.